WPRIM Management System> DCMS> Clinical and Molecular Hepatology> 2018> 24> 3

Volume: 24 Issue: 3

1. Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis. Page:319—330
2. Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study. Page:311—318
3. Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling. Page:302—310
4. Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?. Page:299—301
5. Prognostic implications of trunk muscle mass in liver cirrhosis. Page:297—298
6. Does the old-fashioned sofosbuvir plus ribavirin treatment in genotype 2 chronic hepatitis C patients still works for Koreans?. Page:294—296
7. Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL. Page:278—293
8. Transarterial embolization for the treatment of complicated liver hemangiomas: A report of two cases and review of the literature. Page:345—349
9. Adefovir-induced Fanconi syndrome associated with osteomalacia. Page:339—344
10. Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease. Page:331—338

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.